A new approach to Clinical Trial Solutions, maximising efficiency and minimising costs.
The pharmaceutical industry, as well as many others, was impacted hugely by the Covid-19 pandemic, which included clinical trial development . With hindsight some would now say that Covid put a lens on the key problem areas that had always existed and acted as a catalyst for innovation.
This webinar will start with a presentation by Simon Estcourt, Managing Director, who will explain the rationale for Aposave being rebranded to Abacus Medicine Pharma Services and the benefits that this brings to our CTS clients.
Ian Hoban, Business Development Director and lead for Clinical Trial Solutions will then go into more detail about what synergies between Pharma Services and Abacus Medicine means to our clients and how our service addresses the challenges faced by Clinical Trial Supplies professionals.
Conclusively, Martin Harper, VP Pharma Services will then discuss a specific case study which highlights the benefits and value that our new generation services offer clients.
If you’re a Clinical Trial Supplies professional responsible for sourcing comparator medicines and are interested to hear about a new approach this webinar is a must-see.
Presented by
Simon Estcourt,
Managing Director
A senior executive in the Pharma Services industry Simon brings over 25 years of experience to Abacus Medicine Pharma Services.
His career moved quickly after joining Servier where he became UK Sales Director, before broadening his horizons and a move to Quintiles. He worked with many of the leading pharma manufacturers in global operational and business development roles.
In 2007 he joined Idis to establish the Pharmaceutical Services Division and led on strategy and corporate development for the organisation. Simon and his teams developed a new category of pharmaceutical service that has now become known as Managed Access Programs.
Working in partnership with over 70 pharma and biotech companies these programs benefitted thousands of patients globally who were able to access previously unavailable medicines.
The success of Idis led to an acquisition by Clinigen, where Simon continued as Chief Operating Officer and latterly Chief Strategy Officer.
Martin Harper ,
Vice President – Pharma Services
With over 20 years of experience in the Pharma and Healthcare Services industry Martin joined Abacus Medicine Pharma Services in July 2019. He began his career with UniChem Limited in 1997 and progressed through a number of Commercial and Sales Support roles. As the business grew and became Alliance Healthcare Martin took on a range of management roles in the commercial team. He played an important part in the launch of the Direct-to-Pharmacy model in the UK pharmaceutical supply chain.
This success was rewarded with a move to Commercial Director, Alcura, where he focussed on new customer channels and helped rapidly grow this new clinical homecare business.
He returned to Alliance Healthcare, leading the unlicensed medicines category, and then on to
become Head of Strategy, where he worked on key initiatives for Walgreens Boots Alliance UK.
Ian Hoban,
Business Development Director - CTS
Ian has 30 years of pharmaceutical industry experience, predominantly within global organisations such as Pfizer and Eli Lilly. He built his reputation in the commercialisation of numerous brands in a variety of disease areas, and at every stage of the product lifecycle.
During his career, Ian has worked closely with supply chain, ensuring accurate forecasting, and getting medicines to patients through the implementation of novel approaches.
Before joining Abacus Medicine Pharma Services Ian worked in senior roles at two leading Global Clinical Solutions companies. He provided many leading pharmaceutical and biotechnology companies with successful Comparator Sourcing Solutions which helped successfully deliver their pivotal late phase clinical trials.
